Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Shanghai Virogin Biotech Co., Ltd.

Clinical trials sponsored by Shanghai Virogin Biotech Co., Ltd., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Modified virus takes on tough tumors in early trial Results expected May 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

Modified virus takes on tough tumors in early trial

Disease control Recruiting now

This early-stage study tests a new treatment called VG2062, a modified virus designed to attack cancer cells. It is for 30 adults with advanced solid tumors that have not responded to standard treatments. The main goal is to check safety and find the best dose for future studies.

Phase 1 • Sponsor: Shanghai Virogin Biotech Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 12:00 UTC